Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine.

New amides of different fatty acids from the C18, C20, and C22 series with dopamine were synthesized. Pharmacological characterization in binding assays with rat brain membrane preparations and in the 'tetrad' of cannabinoid behavioral tests showed that, for these compounds, cannabinoid-like activity was dependent on the fatty acid moiety. Our data demonstrate that polyenoic fatty acid amides with dopamine comprise a new family of synthetic cannabimimetics.

[1]  B. Thomas,et al.  Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. , 1997, Journal of medicinal chemistry.

[2]  S. Henriksen,et al.  Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules. , 1998, Current pharmaceutical design.

[3]  V. Showalter,et al.  Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells. , 1997, Biochemical pharmacology.

[4]  R. Mechoulam,et al.  Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs , 1991, Pharmacology Biochemistry and Behavior.

[5]  L. Petrocellis,et al.  Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. , 1999, Current medicinal chemistry.

[6]  T R LaHann,et al.  Vanilloids. 1. Analogs of capsaicin with antinociceptive and antiinflammatory activity. , 1993, Journal of medicinal chemistry.

[7]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[8]  K. Mackie,et al.  Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. , 1993, Molecular pharmacology.

[9]  M. Cebeira,et al.  The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. , 1995, Life sciences.

[10]  R. Pertwee.  The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice , 1972, British journal of pharmacology.

[11]  L. Petrocellis,et al.  N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. , 2000, The Biochemical journal.

[12]  R. Mechoulam,et al.  Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate Cyclase , 1993, Journal of neurochemistry.

[13]  Bobrov MYu,et al.  Bioactive amides of fatty acids. , 1998, Biochemistry. Biokhimiia.

[14]  R. Lerner,et al.  Chemical characterization of a family of brain lipids that induce sleep. , 1995, Science.